The HCA National Disease Management Program for coronary disease detection and treatment in women

L J Shaw1, L Tarkington, T Callister

  • 1Department of Quality, Clinical Cardiovascular Management Network, HCA The Healthcare Company, Nashville, TN, USA. lshaw@hsrd.emory.edu

Insights

Improving diagnosis and treatment for women with heart disease is crucial. HCA Healthcare

Area of Science:

  • Cardiovascular Medicine
  • Women's Health

Background:

  • Heart disease diagnosis and treatment in women remain significant challenges in cardiovascular medicine.
  • Despite reduced mortality rates over 20 years, women's outcomes have not improved.
  • Early diagnosis and timely, effective therapies are critical for improving survival rates in women.

Purpose of the Study:

  • To describe the initial phases of a coordinated national program by HCA Healthcare Systems, Inc. to enhance coronary disease diagnosis in women.
  • To target women requiring aggressive risk factor modification and cardiology referral.
  • To establish an outcomes assessment program for tracking at-risk women.

Main Methods:

  • Initiated a coordinated effort across 208 hospitals in 26 states starting in 1999.
  • Implemented employee risk factor screening and citywide health risk assessments.
  • Developed nationwide educational programs for clinicians, staff, and consumers.
  • Established a dedicated outcomes assessment program for tracking women at risk.

Main Results:

  • The program focused on early diagnosis and aggressive risk factor management for women.
  • Educational initiatives targeted healthcare professionals and the public.
  • An outcomes assessment program was created to monitor progress.

Conclusions:

  • The described efforts aim to provide optimal care and improve outcomes for women with cardiovascular disease.
  • This initiative represents a significant step towards addressing gender disparities in heart disease treatment.
  • Continued focus on early detection and intervention is key to advancing women's cardiovascular health.

Related Concept Videos

Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...